The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...
Hysterosalpingography (HSG) remains a cornerstone diagnostic and potentially therapeutic procedure in the evaluation of female infertility. The technique involves the injection of contrast media into ...
Radiocontrast media play a pivotal role in diagnostic imaging; however, their administration is not without risk. Hypersensitivity reactions, which can range from mild skin eruptions to severe ...
New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027 i Demand for CT and X-Ray contrast media, ...
Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...
Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in the Emerald Isle. The company is pumping $138 million into its Carrigtwohill ...
A research team has demonstrated the clinical feasibility and safety of non-contrast optical coherence tomography (OCT) for patients with coronary artery disease. Intracoronary OCT enables physicians ...
Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington and presented at the 2022 Radiological Society of North America (RSNA) Congress, ...
A new study published in JAMA Network Open highlights the significant environmental footprint of medical imaging contrast agents, finding that Medicare patients alone received 13.5 billion milliliters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results